Literature DB >> 2788864

Increased survival of low birth weight infants: impact on the incidence of retinopathy of prematurity.

P H Valentine1, J C Jackson, R E Kalina, D E Woodrum.   

Abstract

Retinopathy of prematurity is a retinal vascular disease that occurs only in premature infants. Because of concern that the occurrence of this potentially blinding disease is increasing, a retrospective chart review was undertaken to compare the incidence of retinopathy of prematurity at the University of Washington during the years 1981 to 1984 with previously published data collected at the same institution during the years 1968 to 1980. During 1981 to 1984, there was an increase in the annual numbers of admissions and survivors weighing 1750 g at birth; the survival rate increased significantly (P less than .000001). A trend toward an increased risk for proliferative retinopathy of prematurity (P = .057) during 1981 to 1984 period was noted, but the number of "excess cases" was calculated to be only 6 per year. The remainder of the additional cases, 19 annually, were due to increased survival of infants at risk. Thus, the "second epidemic" of retinopathy of prematurity is largely due to improved survival of low birth weight infants rather than to new iatrogenic factors. In infants with proliferative retinopathy of prematurity, there was a previously unreported association between increased severity of disease and lower birth weight (P = .015). There were four children with severe bilateral visual loss due to retinopathy of prematurity identified during the 1981 to 1984 period, whereas only one bilaterally blind infant was noted during the preceding 12.7 years.

Entities:  

Mesh:

Year:  1989        PMID: 2788864

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  24 in total

1.  Severe retinopathy of prematurity and its association with different rates of survival in infants of less than 1251 g birth weight.

Authors:  J Vyas; D Field; E S Draper; G Woodruff; A R Fielder; J Thompson; N J Shaw; D Clark; R Gregson; J Burke; G Durbin
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2000-03       Impact factor: 5.747

2.  Reduced incidence of retinopathy of prematurity.

Authors:  E Rowlands; A C Ionides; S Chinn; H Mackinnon; C C Davey
Journal:  Br J Ophthalmol       Date:  2001-08       Impact factor: 4.638

Review 3.  Retinopathy of prematurity: recent advances in our understanding.

Authors:  C M Wheatley; J L Dickinson; D A Mackey; J E Craig; M M Sale
Journal:  Br J Ophthalmol       Date:  2002-06       Impact factor: 4.638

Review 4.  Retinopathy of prematurity: recent advances in our understanding.

Authors:  C M Wheatley; J L Dickinson; D A Mackey; J E Craig; M M Sale
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2002-09       Impact factor: 5.747

5.  Ophthalmological morbidity in very-low-birthweight infants with bronchopulmonary dysplasia.

Authors:  O A Ajayi; D Raval; N Lucheese; R S Pildes
Journal:  J Natl Med Assoc       Date:  1997-10       Impact factor: 1.798

6.  Three year visual outcome for treated stage 3 retinopathy of prematurity: cryotherapy versus laser.

Authors:  I A Pearce; F C Pennie; L M Gannon; A M Weindling; D I Clark
Journal:  Br J Ophthalmol       Date:  1998-11       Impact factor: 4.638

7.  Retinopathy of prematurity in a controlled trial of prophylactic surfactant treatment.

Authors:  P M Pennefather; W Tin; M P Clarke; S Fritz; N P Strong
Journal:  Br J Ophthalmol       Date:  1996-05       Impact factor: 4.638

8.  Dopamine use is an indicator for the development of threshold retinopathy of prematurity.

Authors:  M B Mizoguchi; T G Chu; F M Murphy; N Willits; L S Morse
Journal:  Br J Ophthalmol       Date:  1999-04       Impact factor: 4.638

9.  Characteristics of severe retinopathy of prematurity patients in China: a repeat of the first epidemic?

Authors:  Y Chen; X Li
Journal:  Br J Ophthalmol       Date:  2006-03       Impact factor: 4.638

10.  Follow-up study on premature infants with and without retinopathy of prematurity.

Authors:  R Robinson; M O'Keefe
Journal:  Br J Ophthalmol       Date:  1993-02       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.